# INSPIRE (NCT04216290)

> A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04216290
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: National Cancer Institute (NCI)
- Conditions: Bladder Urothelial Carcinoma; Stage III Bladder Cancer AJCC v8
- Interventions: Biopsy of Bladder; Biospecimen Collection; Cisplatin; Computed Tomography; Cystoscopy; Durvalumab; Fluorouracil; Gemcitabine Hydrochloride; Magnetic Resonance Imaging; Mitomycin; Patient Observation; Radiation Therapy
- Enrollment: 11
- Primary outcome: Clinical complete response (CR)

## Indexed commentary on INSPIRE so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 3

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=inspire-nct04216290